Unique ID issued by UMIN | UMIN000030859 |
---|---|
Receipt number | R000035234 |
Scientific Title | Examination on an effect of continuous intake of a test food product on improving cognitive function in young adults. |
Date of disclosure of the study information | 2018/01/18 |
Last modified on | 2018/04/18 13:18:17 |
Examination on an effect of continuous intake of a test food product on improving cognitive function in young adults.
Examination on an effect of continuous intake of a test food product on improving cognitive function in young adults.
Examination on an effect of continuous intake of a test food product on improving cognitive function in young adults.
Examination on an effect of continuous intake of a test food product on improving cognitive function in young adults.
Japan |
Healthy subjects
Adult |
Others
NO
To examine an influence of a test food product on cognitive function in healthy Japanese males and females aged 25 and over, below 35 by assigning them to take the test food product for 2 weeks on a continuous basis.
Efficacy
Cognitrax, Uchida-Kraepelin test, VAS
Hematologic test, blood biochemical test, vital signs
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Prevention
Food |
2-week intake of the test food
2-week intake of the placebo food
25 | years-old | <= |
35 | years-old | > |
Male and Female
1)Age: 25 and over, below35
2)Sex: Males and females with Japanese nationality
3)Those who are able to take 9 capsules a day for 2 weeks
4)Non-smoker
5)Workers (excluding students)
1)Currently in treatment with medication or seeing a doctor for treatment
2)Previous history of hepatic disorder or severe disorder related to kidney, endocrine, cardiovascular system, gastro-intestine, lung, blood, or metabolism, or currently presence of complications
3)Previous history of drug allergy or food allergy
4)Regular intake of a food product or supplements with a possible influence on cognitive function
5)Regular intake of drug with a possible influence on cognitive function
6)Extreme faddiness
7)Extremely irregular lifestyle such as a dietary pattern and a sleeping pattern
8)Suspicion of insomnia
9)Presence or previous history of mental disorder (depression, etc.)
10)Presence or previous history of alcoholism
11)Current participation in another clinical trial or participation in another clinical trial within the last three months
12)Irregular work hours such as working on night shift
13)Determined by the investigator to be unsuitable for enrollment in this study
42
1st name | |
Middle name | |
Last name | Takihara Takanobu |
ITO EN, Ltd.
Central Research Institute
21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan
0548-54-1247
t-takihara@itoen.co.jp
1st name | |
Middle name | |
Last name | Ochitani Daisuke |
HUMA R&D CORP
Clinical Development Division
Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
81-3-3431-1260
ochitani@huma-c.co.jp
HUMA R&D CORP
ITO EN,LTD.
Profit organization
NO
2018 | Year | 01 | Month | 18 | Day |
Unpublished
Completed
2017 | Year | 12 | Month | 08 | Day |
2018 | Year | 01 | Month | 28 | Day |
2018 | Year | 01 | Month | 17 | Day |
2018 | Year | 04 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035234